Pyxis Oncology, Inc. (PYXS)

Latest Insider Confidence Score

2026Q1

50.0
Bullish

Company insider confidence (by quarter)

2021Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Connealy Pamela Ann CFO 1,199,143 Nov 27, 2024
Sullivan Lara CEO 1,071,242 Mar 28, 2024
Bayer World Investments B.V. — 955,507 Oct 15, 2021
Bayer Aktiengesellschaft — 955,507 Oct 15, 2021
Chen Bihua Director 668,854 Oct 15, 2021

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 3, 2026 Feb 5, 2026 Civik Thomas CEO Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Sullivan Lara CEO Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Metzger Michael A Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Wadhane Jitendra SVP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 HUMPHREY RACHEL Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Lewis-Hall Freda C Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Dupont Jakob Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Palani Santhosh Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 Connealy Pamela Ann CFO Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 2, 2025 FLAVIN JOHN L Director Neutral 52.5 - 0.00% ✗ -
Dec 23, 2024 Dec 23, 2024 Sullivan Lara CEO Neutral 52.5 - 0.00% ✗ -
Dec 23, 2024 Dec 23, 2024 Connealy Pamela Ann CFO Neutral 52.5 - 0.00% ✗ -
Dec 23, 2024 Dec 23, 2024 Wadhane Jitendra SVP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Nov 26, 2024 Nov 27, 2024 Connealy Pamela Ann CFO Buy 87.5 +88,850 3.99% ✗ $174.4K
Jun 10, 2024 Jun 10, 2024 Metzger Michael A Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Metzger Michael A Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 7, 2024 Palani Santhosh Director Neutral 90.0 +6,000 100.00% ✗ -
Mar 26, 2024 Mar 28, 2024 Connealy Pamela Ann CFO Neutral 90.0 +328,710 42.06% ✗ -
Mar 26, 2024 Mar 28, 2024 Sullivan Lara CEO Neutral 52.5 - 0.00% ✗ -
Mar 26, 2024 Mar 28, 2024 FLAVIN JOHN L Director Neutral 85.0 +35,219 9.32% ✗ -
Mar 26, 2024 Mar 28, 2024 Cline Darren S Director Neutral 90.0 +35,219 16.29% ✗ -
Mar 26, 2024 Mar 28, 2024 Lewis-Hall Freda C Director Neutral 90.0 +35,219 17.08% ✗ -
Mar 26, 2024 Mar 28, 2024 Dupont Jakob Director Neutral 90.0 +38,741 100.00% ✗ -
Mar 26, 2024 Mar 28, 2024 HUMPHREY RACHEL Director Neutral 90.0 +38,741 66.72% ✗ -
Mar 26, 2024 Mar 28, 2024 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Mar 26, 2024 Mar 28, 2024 Wadhane Jitendra SVP, Chief Accounting Officer Neutral 90.0 +131,484 49.26% ✗ -
Mar 12, 2024 Mar 13, 2024 Palani Santhosh Director Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Palani Santhosh Director Neutral 52.5 - 0.00% ✗ -
Dec 29, 2023 Dec 29, 2023 Kobayashi Ken Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 6, 2023 Kobayashi Ken Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 29, 2023 Nov 30, 2023 Connealy Pamela Ann CFO Sell 22.5 -36,949 -4.51% ✗ $51.7K
Nov 15, 2023 Nov 17, 2023 Wadhane Jitendra Chief Accounting Officer Neutral 90.0 +40,000 17.63% ✗ -
Sep 28, 2023 Sep 28, 2023 Connealy Pamela Ann CFO Buy 68.8 +8,000 0.99% ✗ $15K
Sep 27, 2023 Sep 27, 2023 Wadhane Jitendra Chief Accounting Officer Buy 77.5 +2,500 1.11% ✗ $4.7K
Sep 27, 2023 Sep 27, 2023 Connealy Pamela Ann CFO Buy 68.8 +6,426 0.80% ✗ $11.9K
Sep 22, 2023 Sep 26, 2023 Dupont Jakob Director Neutral 52.5 - 0.00% ✗ -
Sep 25, 2023 Sep 25, 2023 Wadhane Jitendra Chief Accounting Officer Buy 77.5 +5,000 2.28% ✗ $8.9K
Sep 25, 2023 Sep 25, 2023 Connealy Pamela Ann CFO Buy 78.8 +12,000 1.51% ✗ $20K
Sep 22, 2023 Sep 22, 2023 Wadhane Jitendra Chief Accounting Officer Buy 77.5 +2,500 1.15% ✗ $4.3K
Sep 22, 2023 Sep 22, 2023 Connealy Pamela Ann CFO Buy 67.5 +5,000 0.64% ✗ $8.7K
Sep 14, 2023 Sep 18, 2023 Sullivan Lara CEO Sell 43.8 -8,641 -0.36% ✗ $18.2K
Sep 11, 2023 Sep 13, 2023 Sullivan Lara CEO Sell 20.0 -212,659 -8.10% ✗ $456.8K
Sep 7, 2023 Sep 8, 2023 Connealy Pamela Ann CFO Neutral 90.0 +187,793 31.60% ✗ -
Sep 7, 2023 Sep 8, 2023 Wadhane Jitendra Chief Accounting Officer Neutral 90.0 +93,896 79.55% ✗ -
Sep 7, 2023 Sep 8, 2023 Sullivan Lara CEO Neutral 90.0 +469,483 21.78% ✗ -
Aug 23, 2023 Aug 25, 2023 Dupont Jakob Director Neutral 52.5 - 0.00% ✗ -
Aug 25, 2023 Dupont Jakob Director Neutral 52.5 - 0.00% ✗ -
Mar 24, 2023 Mar 28, 2023 Sullivan Lara CEO Neutral 90.0 +703,379 48.43% ✗ -
Mar 24, 2023 Mar 28, 2023 Yanchik Connealy Pamela CFO Neutral 90.0 +209,803 54.56% ✗ -
Mar 24, 2023 Mar 28, 2023 Feingold Jay Chief Medical Officer Neutral 90.0 +209,803 40.30% ✗ -
Mar 24, 2023 Mar 28, 2023 Wadhane Jitendra Chief Accounting Officer Neutral 90.0 +74,393 56.23% ✗ -
Mar 24, 2023 Mar 28, 2023 Lewis-Hall Freda C Director Neutral 90.0 +139,355 208.52% ✗ -
Mar 24, 2023 Mar 28, 2023 HUMPHREY RACHEL Director Neutral 90.0 +58,064 100.00% ✗ -
Mar 24, 2023 Mar 28, 2023 FLAVIN JOHN L Director Neutral 90.0 +139,355 58.44% ✗ -
Mar 24, 2023 Mar 28, 2023 Cline Darren S Director Neutral 90.0 +139,355 181.38% ✗ -
Mar 24, 2023 Mar 28, 2023 Civik Thomas Director Neutral 90.0 +139,355 168.85% ✗ -
Jan 3, 2023 Jan 3, 2023 Sullivan Lara CEO Neutral 85.0 +95,684 7.05% ✗ -
Jan 3, 2023 Jan 3, 2023 Feingold Jay Chief Medical Officer Neutral 90.0 +53,931 11.56% ✗ -
Jan 3, 2023 Jan 3, 2023 Yanchik Connealy Pamela CFO Neutral 90.0 +43,493 12.75% ✗ -
Aug 11, 2022 Aug 15, 2022 HUMPHREY RACHEL Director Neutral 52.5 - 0.00% ✗ -
Aug 15, 2022 HUMPHREY RACHEL Director Neutral 52.5 - 0.00% ✗ -
Aug 9, 2022 Wadhane Jitendra SVP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Apr 21, 2022 Apr 25, 2022 Chin Mark Other Sell 16.3 -1,745,761 -100.00% ✗ $5.3M
Apr 14, 2022 Apr 15, 2022 Yanchik Connealy Pamela CFO Neutral 90.0 +93,493 37.77% ✗ -
Apr 14, 2022 Apr 15, 2022 Feingold Jay Chief Medical Officer Neutral 90.0 +115,931 33.06% ✗ -
Apr 14, 2022 Apr 15, 2022 Sullivan Lara CEO Neutral 90.0 +315,273 30.28% ✗ -
Mar 31, 2022 Apr 4, 2022 FLAVIN JOHN L Director Neutral 90.0 +66,831 38.94% ✗ -
Mar 31, 2022 Apr 4, 2022 Feingold Jay Chief Medical Officer Neutral 90.0 +306,930 701.55% ✗ -
Mar 31, 2022 Apr 4, 2022 Sullivan Lara CEO Neutral 90.0 +742,574 248.53% ✗ -
Mar 31, 2022 Apr 4, 2022 Civik Thomas Director Neutral 90.0 +66,831 425.68% ✗ -
Mar 31, 2022 Apr 4, 2022 Cline Darren S Director Neutral 90.0 +66,831 668.31% ✗ -
Mar 31, 2022 Apr 4, 2022 Chin Mark Director Neutral 82.5 +66,831 3.83% ✗ -
Mar 31, 2022 Apr 4, 2022 Yanchik Connealy Pamela CFO Neutral 90.0 +247,524 100.00% ✗ -
Mar 31, 2022 Apr 4, 2022 Lewis-Hall Freda C Director Neutral 90.0 +66,831 100.00% ✗ -
Dec 8, 2021 Dec 9, 2021 Cline Darren S Director Buy 95.0 +10,000 100.00% ✗ $93.9K
Dec 6, 2021 Dec 7, 2021 Yanchik Connealy Pamela CFO Neutral 52.5 - 0.00% ✗ -
Nov 18, 2021 Nov 19, 2021 Civik Thomas Director Buy 95.0 +15,700 100.00% ✗ $200K
Oct 13, 2021 Oct 15, 2021 Chin Mark Director Buy 100.0 +312,500 21.80% ✗ $5M
Oct 13, 2021 Oct 15, 2021 FLAVIN JOHN L Director Neutral 52.5 - 0.00% ✗ -
Oct 13, 2021 Oct 15, 2021 Bayer World Investments B.V. Other Neutral 52.5 - 0.00% ✗ -
Oct 13, 2021 Oct 15, 2021 Cormorant Asset Management, LP Other Buy 100.0 +450,000 67.28% ✗ $7.2M
Oct 7, 2021 Oct 12, 2021 Civik Thomas Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 FLAVIN JOHN L Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Feingold Jay Chief Medical Officer Neutral 90.0 +43,750 100.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Chin Mark Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Lewis-Hall Freda C Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Sullivan Lara CEO Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Herbst Ronald Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Oct 12, 2021 Shah Ritu COO Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Sullivan Lara CEO Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Shah Ritu COO Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 FLAVIN JOHN L Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Herbst Ronald Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Bayer World Investments B.V. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Feingold Jay Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Cline Darren S Director Neutral 52.5 - 0.00% ✗ -
Oct 7, 2021 Yanchik Connealy Pamela CFO Neutral 52.5 - 0.00% ✗ -